EcoDrugPlus

Prostaglandin F Receptor

Ensembl ID : ENSOPRG00000000379
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSOPRG00000000076
Gene Symbol: PTGIR
2 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSOPRG00000010420
Gene Symbol: PTGS1
1 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSOPRG00000013139
Gene Symbol: PTGS2
3 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSOPRG00000013677
Gene Symbol: PSMA1
1 Cross references
263 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSOPRG00000011793
Gene Symbol: PSMA2
1 Cross references
230 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSOPRG00000002835
Gene Symbol: PSMA3
1 Cross references
232 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSOPRG00000008863
Gene Symbol: PSMA5
3 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSOPRG00000014580
Gene Symbol: PSMA6
1 Cross references
277 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSOPRG00000000450
Gene Symbol: PSMA7
1 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSOPRG00000006425
Gene Symbol: PSMB1
1 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSOPRG00000013823
Gene Symbol: PSMB10
3 Cross references
171 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).